Presentation is loading. Please wait.

Presentation is loading. Please wait.

THE CARDIOVASCULAR EFFECTS OF COCAINE Bryan Schwartz, MD, Shereif Rezkalla, MD, Robert Kloner, MD, PhD.

Similar presentations


Presentation on theme: "THE CARDIOVASCULAR EFFECTS OF COCAINE Bryan Schwartz, MD, Shereif Rezkalla, MD, Robert Kloner, MD, PhD."— Presentation transcript:

1 THE CARDIOVASCULAR EFFECTS OF COCAINE Bryan Schwartz, MD, Shereif Rezkalla, MD, Robert Kloner, MD, PhD

2 Why should cardiologists care about cocaine?
Cocaine accounted for 31% of ER visits related to drug misuse or abuse. Of 233 ER visits by cocaine-using patients: 56% presented with cardiovascular complaints, 40% presented with chest pain. Cocaine users have higher incidence of MI (OR ). Risk of MI increases by 24-fold in 1ST hr after cocaine use. Cocaine contributes to ~1/4 MIs in persons years. Volkow ND. National Institute on Drug Abuse Brody SL. Am J Med 1990;88:325. Aslibekyan S. Am J Cardiol. 2008;102:966. Mittleman MA. Circulation. 1999;99:2737. Qureshi AI. Circulation. 2001;103:502.

3 PATHOPHYSIOLOGY COCAINE DEATH ↑ Sympathetic output ↑ catecholamines
↓ Na transport Local anesthetic effect Coronary spasm / vasoconstriction ↑ Platelet adherence / thrombus ↑ Heart rate ↑ Blood pressure ↑ Contractility ↓ O2 supply ↑ O2 demand Arrhythmia QRS prolongation QT prolongation ↓ LV function Ischemia Infarction DEATH

4 PATHOPHYSIOLOGY Causes myocardial O2 supply-demand mismatch
Worsens myocardial performance Causes cardiovascular disease Causes clinical cardiovascular endpoints ↑Heart rate ↑Blood pressure ↓Coronary artery diameter ↓Coronary blood flow ↓Ejection fraction ↑End-systolic volume ↑End-diastolic pressure ↑Deceleration time ↑Left ventricular hypertrophy Arrhythmias QT prolongation Thrombosis Atherosclerosis Endothelial dysfunction Microvascular disease Myocardial infarction CHF Cardiomyopathy Aortic dissection Endocarditis Sudden death

5 PATHOPHYSIOLOGY Causes myocardial O2 supply-demand mismatch
Worsens myocardial performance Causes cardiovascular disease Causes clinical cardiovascular endpoints ↑Heart rate ↑Blood pressure ↓Coronary artery diameter ↓Coronary blood flow ↓Ejection fraction ↑End-systolic volume ↑End-diastolic pressure ↑Deceleration time ↑Left ventricular hypertrophy Arrhythmias QT prolongation Thrombosis Atherosclerosis Endothelial dysfunction Microvascular disease Myocardial infarction CHF Cardiomyopathy Aortic dissection Endocarditis Sudden death

6 COCAINE-ASSOCIATED CHEST PAIN PRESENTATION
MI occurs in ~6% of all patients with CACP CACP and MI can result from any route of administration Predominantly male cigarette smokers aged yrs Cardiovascular risk factors are less prevalent than in patients with traditional MI Presenting symptoms similar to patients with traditional MI EKG is frequently abnormal, rarely indicates ischemia .

7 COCAINE-ASSOCIATED CHEST PAIN PRESENTATION
MI occurs in ~6% of all patients with CACP CACP and MI can result from any route of administration Predominantly male cigarette smokers aged yrs Cardiovascular risk factors are less prevalent than in patients with traditional MI Presenting symptoms similar to patients with traditional MI EKG is frequently abnormal, rarely indicates ischemia . NOTHING DIFFERENTIATES PATIENTS WITH CACP WITH VS. WITHOUT MI

8 COCAINE ASSOCIATED CHEST PAIN DIAGNOSIS
High-risk patients (42/344; 12%) directly admitted Non high-risk cocaine using patients (302) were enrolled in a 12-hour observation protocol: Troponin at presentation and after 3, 6, and 9 hours Continuous 12-lead ST-segment monitoring None of 302 developed MI, arrhythmias or CHF in the observation unit and all were discharged from the unit. At 30 days: None died of CV causes 25% experienced recurrent chest pain 1.3% developed nonfatal MI (all 4 continued to use cocaine and had at least 2 cardiac risk factors). Weber JE. N Engl J Med. 2003;348:510.

9 COCAINE ASSOCIATED CHEST PAIN PROGNOSIS
COHORT MI Death CHF Supraventri cular tachy- arrhythmia Sust- ained VT Brady- arrhythm ia 246 presented to ED with CP 6% 1% 1.6% 1.2% 250 with CP 0% 0.4% 0.8% 302 presented to ED with CP 101 hospitalized with CP 70 hospitalized with CP 31% 1.4% 91 with MI 100% 3% 7% 10% 136 with MI 4% 19%

10 AVOID BETA-BLOCKERS IN COCAINE USING PATIENTS
Beta-blockade can leave alpha-stimulation unopposed → pronounced systemic and coronary vasoconstriction. In animal studies of acute cocaine toxicity, propranolol worsened the seizure threshold and expedited death. In humans, propranolol exacerbated cocaine-induced coronary artery vasoconstriction Esmolol increased blood pressure in 2 of 7 cocaine- using patients (in 1 from 200/120 to 230/180) Catravas JD. J Pharmacol Exp Ther. 1981;217:350. Lange RA. Ann Intern Med. 1990;112:897. Sand IC. Am J Emerg Med. 1991;9:161.

11 AVOID BETA-BLOCKERS IN COCAINE-USING PATIENTS
Labetalol and carvedilol offer the theoretical advantage of blocking both α- and β -receptors. Labetalol did not reverse cocaine-induced coronary artery vasoconstriction. In pheochromocytoma labetalol caused severe hypertension. Combined with cocaine, carvedilol 25mg tended to increase BP. Boehrer JD. Am J Med. 1993;94:608. Briggs RS. Lancet. 1978;1:1045. Sofuoglu M. Drug Alcohol Depend. 2000;60:69.

12 AVOID BETA-BLOCKERS IN COCAINE USING PATIENTS
Risk of exacerbating cocaine-induced coronary and systemic vasoconstriction (reduce myocardial O2 supply and exacerbate hypertension) Benefit unproven in cocaine-using patients. Without beta-blockers complications are low, including death, CHF, arrhythmias.

13 AVOID BETA-BLOCKERS IN COCAINE USING PATIENTS
Risk of exacerbating cocaine-induced coronary and systemic vasoconstriction (reduce myocardial O2 supply and exacerbate hypertension) Benefit unproven in cocaine-using patients. Without beta-blockers complications are low, including death, CHF, arrhythmias. ALWAYS AVOID BETA-BLOCKERS IN THE ACUTE SETTING PRESCRIBE BETA-BLOCKERS AT DISCHARGE ONLY AFTER CAREFUL RISK-BENEFIT ASSESSMENT

14 COCAINE ASSOCIATED CHEST PAIN TREATMENT ALGORITHM
CACP Aspirin Benzodiazepine Nitroglycerin ST-segment elevation? Yes No Yes Chest pain persists? Antithrombotic therapy Antiplatelet therapy Cath lab available? No Primary PCI Yes No Consider thrombolytic therapy only if unequivocal evidence of STEMI Discharge therapy according to published guidelines, including: 12 hours observation: serial EKGs and troponins. NSTEMI or unstable angina? Aspirin Statin Clopidogrel ACE I No Yes Antithrombotic therapy Antiplatelet therapy Consider cardiac catheterization Rule out MI DC from observation unit Timely cardiology follow up Encourage cessation of cocaine and cigarettes Drug abuse counseling

15 COCAINE ASSOCIATED CHEST PAIN TREATMENT ALGORITHM
CACP Aspirin Benzodiazepine Benzodiazepines: Improved BP, HR, acidemia and hyperthermia in dogs Improved chest pain as much as NTG in humans Nitroglycerin ST-segment elevation? Yes No Yes Chest pain persists? Antithrombotic therapy Antiplatelet therapy Cath lab available? No Primary PCI Yes No Consider thrombolytic therapy only if unequivocal evidence of STEMI Discharge therapy according to published guidelines, including: 12 hours observation: serial EKGs and troponins. NSTEMI or unstable angina? Aspirin Statin Clopidogrel ACE I No Yes Antithrombotic therapy Antiplatelet therapy Consider cardiac catheterization Rule out MI DC from observation unit Timely cardiology follow up Encourage cessation of cocaine and cigarettes Drug abuse counseling

16 COCAINE ASSOCIATED CHEST PAIN TREATMENT ALGORITHM
CACP Aspirin Benzodiazepine None of 302 non-high-risk patients developed MI, CHF or arrhythmias in the observation unit and all were discharged from the unit. Nitroglycerin ST-segment elevation? Yes No Yes Chest pain persists? Antithrombotic therapy Antiplatelet therapy Cath lab available? No Primary PCI Yes No Consider thrombolytic therapy only if unequivocal evidence of STEMI Discharge therapy according to published guidelines, including: 12 hours observation: serial EKGs and troponins. NSTEMI or unstable angina? Aspirin Statin Clopidogrel ACE I No Yes Antithrombotic therapy Antiplatelet therapy Consider cardiac catheterization Rule out MI DC from observation unit Timely cardiology follow up Encourage cessation of cocaine and cigarettes Drug abuse counseling

17 COCAINE ASSOCIATED CHEST PAIN TREATMENT ALGORITHM
CACP Aspirin Benzodiazepine Nitroglycerin relieves chest pain in ~1/2 of patients. Nitroglycerin reversed the coronary vasoconstriction induced by cocaine. Nitroglycerin ST-segment elevation? Yes No Yes Chest pain persists? Antithrombotic therapy Antiplatelet therapy Cath lab available? No Primary PCI Yes No Consider thrombolytic therapy only if unequivocal evidence of STEMI Discharge therapy according to published guidelines, including: 12 hours observation: serial EKGs and troponins. NSTEMI or unstable angina? Aspirin Statin Clopidogrel ACE I No Yes Antithrombotic therapy Antiplatelet therapy Consider cardiac catheterization Rule out MI DC from observation unit Timely cardiology follow up Encourage cessation of cocaine and cigarettes Drug abuse counseling

18 COCAINE ASSOCIATED CHEST PAIN TREATMENT ALGORITHM
CACP Aspirin Benzodiazepine 2nd-line therapy for hypertension Ca channel blockers: abolished cocaine’s effects on BP and coronary vasoconstriction in humans Nitroglycerin ST-segment elevation? Yes No Yes Chest pain persists? Antithrombotic therapy Antiplatelet therapy Cath lab available? No Primary PCI Yes No Consider thrombolytic therapy only if unequivocal evidence of STEMI Discharge therapy according to published guidelines, including: 12 hours observation: serial EKGs and troponins. NSTEMI or unstable angina? Aspirin Statin Clopidogrel ACE I No Yes Antithrombotic therapy Antiplatelet therapy Consider cardiac catheterization Rule out MI DC from observation unit Timely cardiology follow up Encourage cessation of cocaine and cigarettes Drug abuse counseling

19 COCAINE ASSOCIATED CHEST PAIN TREATMENT ALGORITHM
CACP Aspirin Benzodiazepine 2nd-line therapy for hypertension Phentolamine: abolished cocaine’s effects on HR, BP, coronary vasoconstriction and coronary sinus blood flow Nitroglycerin ST-segment elevation? Yes No Yes Chest pain persists? Antithrombotic therapy Antiplatelet therapy Cath lab available? No Primary PCI Yes No Consider thrombolytic therapy only if unequivocal evidence of STEMI Discharge therapy according to published guidelines, including: 12 hours observation: serial EKGs and troponins. NSTEMI or unstable angina? Aspirin Statin Clopidogrel ACE I No Yes Antithrombotic therapy Antiplatelet therapy Consider cardiac catheterization Rule out MI DC from observation unit Timely cardiology follow up Encourage cessation of cocaine and cigarettes Drug abuse counseling

20 COCAINE ASSOCIATED CHEST PAIN TREATMENT ALGORITHM
CACP Aspirin Benzodiazepine Nitroglycerin ST-segment elevation? Yes No Yes Chest pain persists? Antithrombotic therapy Antiplatelet therapy Cath lab available? No Primary PCI Yes No Consider thrombolytic therapy only if unequivocal evidence of STEMI Discharge therapy according to published guidelines, including: 12 hours observation: serial EKGs and troponins. NSTEMI or unstable angina? Aspirin Statin Clopidogrel ACE I No Yes Antithrombotic therapy Antiplatelet therapy Consider cardiac catheterization Rule out MI DC from observation unit Timely cardiology follow up Encourage cessation of cocaine and cigarettes Drug abuse counseling

21 COCAINE ASSOCIATED CHEST PAIN TREATMENT ALGORITHM
CACP Aspirin Benzodiazepine Primary PCI is more preferable in cocaine-using patients than traditional STEMI patients because of diagnostic uncertainty; 5-8% risk of stent thrombosis Nitroglycerin ST-segment elevation? Yes No Yes Chest pain persists? Antithrombotic therapy Antiplatelet therapy Cath lab available? No Primary PCI Yes No Consider thrombolytic therapy only if unequivocal evidence of STEMI Discharge therapy according to published guidelines, including: 12 hours observation: serial EKGs and troponins. NSTEMI or unstable angina? Aspirin Statin Clopidogrel ACE I No Yes Antithrombotic therapy Antiplatelet therapy Consider cardiac catheterization Rule out MI DC from observation unit Timely cardiology follow up Encourage cessation of cocaine and cigarettes Drug abuse counseling

22 COCAINE ASSOCIATED CHEST PAIN TREATMENT ALGORITHM
CACP Aspirin Benzodiazepine Primary PCI is more preferable in cocaine-using patients than traditional STEMI patients because of diagnostic uncertainty; 5-8% risk of stent thrombosis Nitroglycerin ST-segment elevation? Yes No Yes Chest pain persists? Antithrombotic therapy Antiplatelet therapy Cath lab available? No Primary PCI Yes No Consider thrombolytic therapy only if unequivocal evidence of STEMI Discharge therapy according to published guidelines, including: 12 hours observation: serial EKGs and troponins. NSTEMI or unstable angina? Aspirin Statin Clopidogrel ACE I No Yes Antithrombotic therapy Antiplatelet therapy Consider cardiac catheterization Rule out MI DC from observation unit Timely cardiology follow up Encourage cessation of cocaine and cigarettes Drug abuse counseling

23 COCAINE ASSOCIATED CHEST PAIN TREATMENT ALGORITHM
CACP Aspirin Benzodiazepine Nitroglycerin ST-segment elevation? Yes No Yes Chest pain persists? Antithrombotic therapy Antiplatelet therapy Cath lab available? No Primary PCI Yes No Consider thrombolytic therapy only if unequivocal evidence of STEMI Discharge therapy according to published guidelines, including: 12 hours observation: serial EKGs and troponins. NSTEMI or unstable angina? Aspirin Statin Clopidogrel ACE I No Yes Antithrombotic therapy Antiplatelet therapy Consider cardiac catheterization Rule out MI DC from observation unit Timely cardiology follow up Encourage cessation of cocaine and cigarettes Drug abuse counseling

24 COCAINE ASSOCIATED CHEST PAIN TREATMENT ALGORITHM
CACP Aspirin Benzodiazepine For patients who discontinue cocaine: MI and death are rare incidence of recurrent chest pain is reduced Nitroglycerin ST-segment elevation? Yes No Yes Chest pain persists? Antithrombotic therapy Antiplatelet therapy Cath lab available? No Primary PCI Yes No Consider thrombolytic therapy only if unequivocal evidence of STEMI Discharge therapy according to published guidelines, including: 12 hours observation: serial EKGs and troponins. NSTEMI or unstable angina? Aspirin Statin Clopidogrel ACE I No Yes Antithrombotic therapy Antiplatelet therapy Consider cardiac catheterization Rule out MI DC from observation unit Timely cardiology follow up Encourage cessation of cocaine and cigarettes Drug abuse counseling

25 COCAINE ASSOCIATED CHEST PAIN CONCLUSION
Predominantly young male cigarette smokers Of patients in ER with CACP: ~6% have MI Evaluate non-high-risk patients with 12 hr observation Cocaine-induced MI: complications are very low, including death, CHF, arrhythmias Avoid all beta-blockers in the acute setting Treat CACP with benzodiazepines, NTG, standard Tx PCI even more preferable than in traditional patients Cocaine cessation is primary therapeutic goal


Download ppt "THE CARDIOVASCULAR EFFECTS OF COCAINE Bryan Schwartz, MD, Shereif Rezkalla, MD, Robert Kloner, MD, PhD."

Similar presentations


Ads by Google